«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:

2016年02期

页码:

110-114

栏目:

临床研究

出版日期:

2016-03-20

文章信息/Info

Title:

Correlation between glycolipid metabolism index and the severity of coronary artery disease

作者:

于佳; 温志超; 洪晋; 李剑; 施海明; 范维琥; 倪唤春; 罗心平

200040 上海,复旦大学附属华山医院心内科

Author(s):

YU Jia; WEN Zhichao;  HONG Jin;  LI Jian;  SHI Haiming;  FAN Weihu;  NI Huanchun; LUO Xinping.

关键词:

冠状动脉粥样硬化性心脏病; 糖化血红蛋白; 低密度脂蛋白胆固醇; 高密度脂蛋白胆固醇

Keywords:

Coronary artery disease;  Hemoglobin A1c;  Low-density lipoprotein cholesterol;  High-density lipoprotein cholesterol

分类号:

-

DOI:

10.3969/j.issn.1673-6583.2016.02.014

文献标识码:

-

摘要:

目的:探讨综合糖脂代谢指标与冠状动脉(冠脉)病变程度的关系及其临床意义。方法:入选2012年3月至2013年12月于我院接受冠脉造影的717例患者,根据造影结果分为冠脉造影阴性的对照组(n=385)和冠心病组(n=332)。检测所有研究对象的血清糖化血红蛋白(HbA1c)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、三酰甘油(TG)等,采用Gensini评分评估冠脉病变严重程度。采用Pearson相关系数分析连续性变量之间的相关性,Spearman相关系数检测分类

Abstract:

Objective: To investigate the relation between comprehensive glycolipid metabolism index and the severity of coronary artery disease.Methods: From March 2012 to December 2013, a total of 385 patients were enrolled into the control group, and 332 patients

参考文献/References

[1] Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010[J]. Lancet,2012,380(9859):2095-2128.
[2] Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins[J]. Lancet,2005,366(9493):1267-1278.
[3] Boekholdt SM, Arsenault BJ, Hovingh GK, et al. Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis[J]. Circulation,2013,128(14):1504-1512.
[4] van't Riet E, Rijkelijkhuizen JM, Alssema M, et al. HbA1c is an independent predictor of non-fatal cardiovascular disease in a Caucasian population without diabetes: a 10-year follow-up of the Hoorn Study[J]. Eur J Prev Cardiol,2012,19(1):23-31.
[5] Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults[J]. N Engl J Med,2010,362(9):800-811.
[6] Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol,1983,51(3):606.
[7] Wang Y, Zheng A, Yan Y, et al. Association between HMW adiponectin, HMW-total adiponectin ratio and early-onset coronary artery disease in Chinese population[J]. Atherosclerosis,2014,235(2):392-397.
[8] National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel III). Third Report of the National Cholesterol Education Program(NCEP)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel Ⅲ)final report[J]. Circulation,2002,106(25):3143-3421.
[9] Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program(NCEP)Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults(Adult Treatment Panel Ⅲ)[J]. JAMA,2001,285(19):2486-2497.
[10] Cholesterol Treatment Trialists'(CTT)Collaboration, Baigent C, Blackwell L, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials[J]. Lancet,2010,376(9753):1670-1681.
[11] Castelli WP, Anderson K, Wilson PW, et al. Lipids and risk of coronary heart disease. The Framingham Study[J]. Ann Epidemiol,1992,2(1-2):23-28.
[12] Gotto AM, Jr. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease[J]. Am Heart J,2002,144(6 Suppl):S33-S42.
[13] Despres JP, Lemieux I, Dagenais GR, et al. HDL-cholesterol as a marker of coronary heart disease risk: the Quebec cardiovascular study[J]. Atherosclerosis,2000,153(2):263-272.
[14] Momiyama Y, Ohmori R, Fayad ZA, et al. The LDL-cholesterol to HDL-cholesterol ratio and the severity of coronary and aortic atherosclerosis[J]. Atherosclerosis,2012,222(2):577-580.
[15] 吴燕丹. TC/HDL-C、LDL-C/HDL-C、TG/HDL-C与冠心病不同程度相关性[J]. 临床误诊误治,2014,(6):64-67.
[16] Ueda H, Mitsusada N, Harimoto K, et al. Glycosylated hemoglobin is a predictor of major adverse cardiac events after drug-eluting stent implantation in patients with diabetes mellitus[J]. Cardiology,2010,116(1):51-57.
[17] Kataoka Y, Shao M, Wolski K, et al. Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus[J]. Eur J Prev Cardiol,2013,20(2):209-217.
[18] Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition(EPIC-Norfolk)[J]. BMJ,2001,322(7277):15-18.
[19] Ashraf H, Boroumand MA, Amirzadegan A, et al. Hemoglobin A1C in non-diabetic patients: an independent predictor of coronary artery disease and its severity[J]. Diabetes Res Clin Pract,2013,102(3):225-232.
[20] Xu RX, Li S, Li XL, et al. High-density lipoprotein subfractions in relation with the severity of coronary artery disease: A Gensini score assessment[J]. J Clin Lipidol,2015,9(1):26-34.
[21] Niccoli G, Baca M, De Spirito M, et al. Impact of electronegative low-density lipoprotein on angiographic coronary atherosclerotic burden[J]. Atherosclerosis,2012,223(1):166-170.

备注/Memo

备注/Memo:

基金项目:上海市卫生局科研项目(20134312) 作者单位:200040 上海,复旦大学附属华山医院心内科 通信作者:倪唤春, Email:docnhc@126.com

常用功能

更新日期/Last Update: 2016-03-20